ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

This study, called ACCESS, is looking at better ways to provide cervical cancer screening and treatment to women living with HIV in Nigeria. It compares two approaches: "Core Implementation Strategies" and "Core+ Enhanced Implementation Strategies." The Core strategies involve ongoing consultation, educational meetings, strengthening referral systems, and preparing patients to be active participants. The Core+ strategies include all of the Core strategies plus community engagement and using "Smart Cards" to help patients stay involved. The study aims to see how well these approaches help women get screened, treated, and stay in care. You may be able to join if you are a woman living with HIV, between 25 and 64 years old. The study is currently unclear about its recruitment status.

Study design
This study plans to include 2436 women and compares two different sets of strategies for providing cervical cancer care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will measure how many people are reached at 12 months after joining and how well the services continue to be used (sustainment) 3 months before the study ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06128304

ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

Recruiting
NAAges 25–64Interventional
University of California, San Diego
~2,436 participants
Updated 2026-02-10 on ClinicalTrials.gov
What's tested:Core Implementation strategiesCore+ Enhanced Implementation Strategies

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Reach
Measured over 12 months after enrollment
+1 more outcome measured
HIV
Cervical Cancer
2 sites across 2 states
California1
Enugu State1
  • Gregory Aarons, PhD · PRINCIPAL_INVESTIGATOR · University of California, San Diego

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Women living with HIV
  • Reach12 months after enrollment

    Percent of WLHIV who had cervical cancer (CC) screening

  • Sustainment3 months prior to study completion

    Provider Report of Sustainment Scale (PRESS; Moullin et al., 2021). The PRESS has 3-items scored from 0 "not at all" to 4 "to a very great extent" where higher scores indicate better evidence-based practice sustainment.